Immunocore Names Non-Executive Board Member as CFO

WSJJan 2 07:34 ET

Immunocore Names Travis Coy Chief Financial Officer

MT NewswiresJan 2 07:28 ET

Express News | Immunocore Appoints Travis Coy, Previously a Non-Executive Director, as Its Evp, Chief Financial Officer and Head of Corporate Development

ReutersJan 2 07:00 ET

Immunocore Advances Half-Life Extended Cancer Treatment With First Patient Dosed

BenzingaDec 23, 2024 07:03 ET

Express News | Immunocore Announces First Patient Dosed in the Phase 1 Trial of Imc-P115C, a Half-Life Extended (Hle) Immtac Candidate in Patients With Tumors That Express Prame

ReutersDec 23, 2024 07:00 ET

Jefferies Maintains Immunocore(IMCR.US) With Buy Rating, Cuts Target Price to $45

Moomoo NewsDec 20, 2024 13:31 ET · Ratings